Join us for the next research initiatives webinar with ECE Professor Brian Cunningham (and ECE alumnus) who will provide an overview of current Illinois Grainger Engineering advancements in cancer research.
When a person goes to the doctor with an infection, they can leave the appointment with a diagnosis and a prescription for antibiotics. Why can’t the same be true for cancer? Oncologists, oral surgeons, gynecologists and patients are all eager to simplify the journey that cancer patients currently face for initial diagnosis, therapy selection, therapy effectiveness monitoring and remission monitoring.
Through a multidisciplinary team science approach that involves Illinois engineers, chemists, biologists and clinical partners, we are developing ultra-sensitive, simple, rapid, quantitatively accurate and inexpensive approaches for detecting molecular biomarkers for cancer.
Prof. Cunningham is the Intel Alumni Endowed Chair in the Department of Electrical and Computer Engineering; professor in the Bioengineering and Chemistry departments; director of the Center for Genomic Diagnostics at the Woese Institute for Genomic Biology; and program leader of Cancer Technology and Data Science for the Cancer Center at Illinois.
Not able to attend on February 18? The webinar will be recorded. Register today, and you will receive an email with the link to the recording once it is available.